Forian

Forian ROCE

Delisted

The Return on Capital Employed (ROCE) of Forian (FORA) as of Oct 22, 2026 is -18.50 %. In the previous year, Return on Capital Employed (ROCE) was -13.17 % — a change of 40.52% (lower).

ROCE

-18.50 %

YoY

40.52%

Last updated:

In 2024, Forian's return on capital employed (ROCE) was -18.50 %, a 40.52% increase from the -13.17 % ROCE in the previous year.

The Forian ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
-687.27 USD
Jan 1, 2018
-17.72 USD
Jan 1, 2019
-15.69 USD
Jan 1, 2020
-44.23 USD
Jan 1, 2021
-104.93 USD
Jan 1, 2022
-208.78 USD
Jan 1, 2023
-13.17 USD
Jan 1, 2024
-18.50 USD
The Forian ROCE history
YEARROCEYoY
-18.50 %+40.52%
-13.17 %-93.69%
-208.78 %+98.97%
-104.93 %+137.24%
-44.23 %+181.90%
-15.69 %-11.44%
-17.72 %-97.42%
-687.27 %-217.21%
586.36 %-544.21%
-132.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forian Stock analysis

What does Forian do? Forian, Inc. generates revenue through its Information and Software segment, which licenses data management and analytics products to healthcare life sciences, payer, and provider customers. The Services segment offers implementation, support, and training services on a contractual basis to these same segments. The Other segment provides security and marketing services, primarily through its security and marketing operations. The company's data management solution organizes, normalizes, standardizes, integrates, enhances, and publishes transactional information for customers across traditional and emerging healthcare sectors. Patient registries solutions help clients understand disease progression, treatment protocols, and therapeutic effectiveness through data-driven insights. Forian's customers within the healthcare payer and provider segments purchase its data management capabilities and analytics tools to optimize operational, clinical, and financial performance. The life sciences segment uses its information and software products for research and development purposes. The company's services include implementation, support, and training, which are contracted by customers seeking to integrate Forian's solutions into their workflows. Security and marketing services in the Other segment are provided to support broader business operations. The Information and Software segment licenses products that include data management and analytics solutions tailored for healthcare organizations. Services segment contracts focus on implementation, support, and training for customers using these solutions. The Other segment's security and marketing services are secondary operations that complement the primary business model. Forian's offerings enable healthcare organizations to measure performance across clinical, operational, and financial dimensions through standardized data processes. Forian is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Forian's Return on Capital Employed (ROCE)

Forian's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Forian's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Forian's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Forian’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Forian stock

Return on Capital Employed (ROCE) of Forian is -18.50 % in 2024.

Return on Capital Employed (ROCE) of Forian changed from -13.17 % to -18.50 %, representing a 40.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Forian since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Forian with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Forian

All Key Metrics — Forian